Related Experiment Videos
Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study
J M Bhatavdekar1, D D Patel, N H Karelia
1Division of Research, Gujarat Cancer Society, Asarwa, Ahmedabad, India.
Breast Cancer Research and Treatment
|January 1, 1994
Abstract:
A retrospective study was performed on 69 breast cancer patients (stage II, N = 18; advanced disease, N = 51) in order to assess the prognostic value of circulating prolactin (PRL), CEA, CA 15-3, insulin-like growth factor-1 (IGF-1), and epidermal growth factor (EGF) by RIA/IRMA. These markers were compared with short-term prognosis (two years). Significant difference was observed only for PRL ( < 20.0 ng/ml vs. > 20.0 ng/ml), which provide an independent predictor of short-term prognosis in advanced breast cancer.